Found: 117
Select item for more details and to access through your institution.
Phase I trial of FOLFIRI in combination with sorafenib and bevacizumab in patients with advanced gastrointestinal malignancies.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 1, p. 96, doi. 10.1007/s10637-015-0308-5
- By:
- Publication type:
- Article
Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 3, p. 740, doi. 10.1007/s10637-014-0154-x
- By:
- Publication type:
- Article
UGT1A1 genotype-guided phase I study of irinotecan, oxaliplatin, and capecitabine.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1559, doi. 10.1007/s10637-013-0034-9
- By:
- Publication type:
- Article
Low E-cadherin and β-catenin expression correlates with increased spontaneous and artificial lung metastases of murine carcinomas.
- Published in:
- Clinical & Experimental Metastasis, 1999, v. 17, n. 2, p. 171, doi. 10.1023/A:1006670918848
- By:
- Publication type:
- Article
Bevacizumab exposure beyond first disease progression in patients with metastatic colorectal cancer: analyses of the ARIES observational cohort study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2014, v. 23, n. 7, p. 726, doi. 10.1002/pds.3633
- By:
- Publication type:
- Article
Long-term follow-up of chemoimmunotherapy with rituximab, oxaliplatin, cytosine arabinoside, dexamethasone (ROAD) in patients with relapsed CD20+ B-cell non-Hodgkin lymphoma: Results of a study of the Mayo Clinic Cancer Center Research Consortium (MCCRC) MC0485 now known as academic and community cancer research united (ACCRU)
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 10, p. 1004, doi. 10.1002/ajh.24824
- By:
- Publication type:
- Article
C-erbB-2/ HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines.
- Published in:
- Oncogene, 2000, v. 19, n. 42, p. 4864, doi. 10.1038/sj.onc.1203838
- By:
- Publication type:
- Article
Napabucasin Plus FOLFIRI in Patients With Previously Treated Metastatic Colorectal Cancer: Results From the Open-Label, Randomized Phase III CanStem303C Study.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 1, p. 100, doi. 10.1016/j.clcc.2022.11.002
- By:
- Publication type:
- Article
Bolus 5-fluorouracil (5-FU) In Combination With Oxaliplatin Is Safe and Well Tolerated in Patients Who Experienced Coronary Vasospasm With Infusional 5-FU or Capecitabine.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Leptomeningeal Carcinomatosis in Colorectal Cancer: The Mayo Clinic Experience.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Comparison of FOLFIRI With or Without Cetuximab in Patients With Resected Stage III Colon Cancer; NCCTG (Alliance) Intergroup Trial N0147.
- Published in:
- Clinical Colorectal Cancer, 2014, v. 13, n. 2, p. 100, doi. 10.1016/j.clcc.2013.12.002
- By:
- Publication type:
- Article
Optimizing Palliative Treatment of Metastatic Colorectal Cancer in the Era of Biologic Therapy.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 5, p. 553
- By:
- Publication type:
- Article
Recognizing and Managing Toxicities of Molecular Targeted Therapies for Colorectal Cancer.
- Published in:
- Oncology (08909091), 2006, v. 20, p. 21
- By:
- Publication type:
- Article
Improving Rectal Cancer Treatments 1 Study at a Time.
- Published in:
- 2023
- By:
- Publication type:
- Opinion
Chemotherapy-Induced Neutropenia as a Prognostic and Predictive Marker of Outcomes in Solid-Tumor Patients.
- Published in:
- Drugs, 2018, v. 78, n. 7, p. 737, doi. 10.1007/s40265-018-0909-3
- By:
- Publication type:
- Article
Napabucasin: An Update on the First-in-Class Cancer Stemness Inhibitor.
- Published in:
- Drugs, 2017, v. 77, n. 10, p. 1091, doi. 10.1007/s40265-017-0759-4
- By:
- Publication type:
- Article
Effect of Oxaliplatinr Fluorouracilr and Leucovorin With or Without Cetuximab on Survival Among Patients With Resected Stage III Colon Cancer.
- Published in:
- JAMA: Journal of the American Medical Association, 2012, v. 307, n. 13, p. 1383
- By:
- Publication type:
- Article
Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal Cancer.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Targeting colorectal cancer with human anti-EGFR monoclonocal antibodies: focus on panitumumab.
- Published in:
- Biologics: Targets & Therapy, 2008, v. 2, n. 2, p. 223
- By:
- Publication type:
- Article
Projecting Event-Based Analysis Dates in Clinical Trials: An Illustration Based on the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) Collaboration. Projecting Analysis Dates for the IDEA Collaboration.
- Published in:
- Forum of Clinical Oncology, 2014, v. 5, n. 2, p. 1, doi. 10.2478/fco-2014-0006
- By:
- Publication type:
- Article
Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Analysis of the Survival Impact of Postoperative Chemotherapy After Preoperative Chemotherapy and Resection for Gastric Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 3, p. 1417, doi. 10.1245/s10434-020-09045-w
- By:
- Publication type:
- Article
Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinoma.
- Published in:
- Journal of Surgical Oncology, 2020, v. 121, n. 8, p. 1320, doi. 10.1002/jso.25899
- By:
- Publication type:
- Article
Reintroduction of Oxaliplatin: A Viable Approach to the Long-Term Management of Metastatic Colorectal Cancer.
- Published in:
- Oncology, 2011, v. 79, n. 5/6, p. 389, doi. 10.1159/000323491
- By:
- Publication type:
- Article
Clinical Outcomes in Elderly Patients with Metastatic Colorectal Cancer Receiving Bevacizumab and Chemotherapy: Results from the BRiTE Observational Cohort Study.
- Published in:
- Oncology, 2010, v. 78, n. 5/6, p. 329, doi. 10.1159/000320222
- By:
- Publication type:
- Article
Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00230-y
- By:
- Publication type:
- Article
Phase I Trial of a Pathotropic Retroviral Vector Expressing a Cytocidal Cyclin G1 Construct (Rexin-G) in Patients With Advanced Pancreatic Cancer.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 5, p. 979, doi. 10.1038/mt.2008.29
- By:
- Publication type:
- Article
Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Reevaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer Trials.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Prognostic and Predictive Impact of Primary Tumor Sidedness for Previously Untreated Advanced Colorectal Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Evaluating Continuous Tumor Measurement-Based Metrics as Phase II Endpoints for Predicting Overall Survival.
- Published in:
- 2015
- By:
- Publication type:
- journal article
The Imperative for a New Approach to Toxicity Analysis in Oncology Clinical Trials.
- Published in:
- 2015
- By:
- Publication type:
- journal article
ACCENT-Based Web Calculators to Predict Recurrence and Overall Survival in Stage III Colon Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 12, p. 1, doi. 10.1093/jnci/dju333
- By:
- Publication type:
- Article
ACCENT-Based Web Calculators to Predict Recurrence and Overall Survival in Stage III Colon Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 12, p. 1, doi. 10.1093/jnci/dju333
- By:
- Publication type:
- Article
Patient and Tumor Characteristics and BRAF and KRAS Mutations in Colon Cancer, NCCTG/Alliance N0147.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 7, p. 1, doi. 10.1093/jnci/dju106
- By:
- Publication type:
- Article
The Challenge to Optimize Medical Therapy for Advanced Colorectal Cancer.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Effect of Regorafenib in Delaying Definitive Deterioration in Health-Related Quality of Life in Patients with Advanced Cancer of Three Different Tumor Types.
- Published in:
- Cancer Management & Research, 2021, v. 13, p. 5523, doi. 10.2147/CMAR.S305939
- By:
- Publication type:
- Article
Patient and physician preferences for anticancer drugs for the treatment of metastatic colorectal cancer: a discrete-choice experiment.
- Published in:
- Cancer Management & Research, 2017, v. 9, p. 149, doi. 10.2147/CMAR.S125245
- By:
- Publication type:
- Article
Curable Metastatic Colorectal Cancer.
- Published in:
- Current Oncology Reports, 2011, v. 13, n. 3, p. 168, doi. 10.1007/s11912-011-0157-0
- By:
- Publication type:
- Article
MODUL—a multicenter randomized clinical trial of biomarker-driven maintenance therapy following first-line standard induction treatment of metastatic colorectal cancer: an adaptable signal-seeking approach.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 6, p. 1197, doi. 10.1007/s00432-018-2632-6
- By:
- Publication type:
- Article
Use of Molecular Assays and Circulating Tumor DNA in Early‐Stage Colorectal Cancer: A Roundtable Discussion of the Gastrointestinal Cancer Therapy Expert Group.
- Published in:
- Oncologist, 2021, v. 26, n. 8, p. 651, doi. 10.1002/onco.13738
- By:
- Publication type:
- Article
Preemptive Versus Reactive Topical Clobetasol for Regorafenib‐Induced Hand‐Foot Reactions: A Preplanned Analysis of the ReDOS Trial.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. 610, doi. 10.1002/onco.13730
- By:
- Publication type:
- Article
Evolution of Cancer Care in Response to the COVID‐19 Pandemic.
- Published in:
- Oncologist, 2020, v. 25, n. 9, p. e1426, doi. 10.1634/theoncologist.2020-0451
- By:
- Publication type:
- Article
In Reply.
- Published in:
- Oncologist, 2020, v. 25, n. 8, p. e1252, doi. 10.1634/theoncologist.2020-0329
- By:
- Publication type:
- Article
A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID‐19) Pandemic: An International Collaborative Group.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. e936, doi. 10.1634/theoncologist.2020-0213
- By:
- Publication type:
- Article
Molecular Analyses of Left‐ and Right‐Sided Tumors in Adolescents and Young Adults with Colorectal Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. 404, doi. 10.1634/theoncologist.2019-0552
- By:
- Publication type:
- Article
Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single‐Arm, Open‐Label Phase IIIb CONSIGN Study.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 185, doi. 10.1634/theoncologist.2018-0072
- By:
- Publication type:
- Article
Outcome of Mismatch Repair‐Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience.
- Published in:
- Oncologist, 2018, v. 23, n. 9, p. 1083, doi. 10.1634/theoncologist.2017-0289
- By:
- Publication type:
- Article